- Truepill, a San Mateo, Calif.-based company building patient experiences through its API-connected healthcare infrastructure, closed a $75m Series C funding
- Backers included Oak HC/FT (lead), and existing investors Optum Ventures, TI Platform Management, Sound Ventures and YCombinator
- The funds will used to launch an at-home lab testing network – a new service that will further expand the company’s ecosystem of direct-to-patient capabilities
- Truepill leverages APIs to provide customized B2B solutions for healthcare companies of all sizes, stages and specialties
- As its customers expand product offerings and enter new markets, Truepill continues enhancing its platform
- The company plans to launch its newest service, at-home lab testing, by end of year
